公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2016 | Prognostic significance of NPM1 mutation-modulated microRNA-mRNA regulation in acute myeloid leukemia | Chiu Y.-C.; MONG-HSUN TSAI ; WEN-CHIEN CHOU ; Liu Y.-C.; Kuo Y.-Y.; HSIN-AN HOU ; TZU-PIN LU ; LIANG-CHUAN LAI ; Chen Y.; HWEI-FANG TIEN ; ERIC YAO-YU CHUANG | Leukemia | 22 | 21 | |
2014 | SF3B1 mutations in patients with myelodysplastic syndromes: The mutation is stable during disease evolution | CHIEN-CHIN LIN ; HSIN-AN HOU ; WEN-CHIEN CHOU ; Kuo Y.-Y.; SHANG-JU WU ; Liu C.-Y.; Chen, Chien-Yuan ; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; JIH-LUH TANG ; MING YAO ; SHANG-YI HUANG ; SZU-CHUN HSU ; BOR-SHENG KO ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | American Journal of Hematology | 30 | 26 | |
2006 | Solution structure of a novel tryptophan-rich peptide with bidirectional antimicrobial activity | B.-S. Yip ; Wei, SY; Wu, JM; Kuo, YY; Chen, HL; Tzeng, SR; Cheng, JW; Kuo Y.-Y.; Chen H.-L.; Yip B.-S.; SHIOU-RU TZENG ; Cheng J.-W. | Journal of Bacteriology | 61 | 60 | |
2011 | TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics | WEN-CHIEN CHOU ; SHENG-CHIEH CHOU ; Liu C.-Y.; Chen, Chien-Yuan ; HSIN-AN HOU ; Kuo Y.-Y.; Lee M.-C.; BOR-SHENG KO ; JIH-LUH TANG ; MING YAO ; WOEI TSAY ; SHANG-JU WU ; SHANG-YI HUANG ; SZU-CHUN HSU ; YAO-CHANG CHEN ; Chang Y.-C.; Kuo Y.-Y.; KUAN-TING KUO ; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; HWEI-FANG TIEN | Blood | 256 | 235 |